TriRx Pharmaceutical Services

Activities: Manufacturing Research & Development

TriRx Pharmaceutical Services is a global contract development and manufacturing organization (CDMO) serving biopharmaceutical and animal health markets

Trending Articles

  1. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  2. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  3. Samsung Biologics bags $668 manufacturing deal with European pharmaceutical company The CDMO will be responsible for the manufacture of the client's biopharmaceuticals until December 2031
  4. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  5. Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Manufacturing

Essential criteria for a successful CDMO partnership

Critical qualities to look for in a CDMO
Finance

TriRx hosted state and community leaders

The celebration commemorated the acquisition of the Shawnee facility previously owned by Elanco Animal Health Incorporated
Regulatory

Fostering a healthy quality culture

In the pharma industry, many use regulatory inspection history and audit reports to get a feel for how a manufacturing operation is run from a compliance/quality standpoint. But TriRx believes these are just one of the many ways to gauge quality history, systems, and culture at an organisation

TriRx acquires Elanco Animal Health Facility in Shawnee, Kansas

TriRx Pharmaceutical Services, LLC, a leading international CDMO, has finalised and closed on an agreement with Elanco Animal Health Incorporated to acquire the ownership and operations of its manufacturing site in Shawnee, Kansas
Manufacturing

Building an integrated and effective CDMO from the ground up

CDMOs are a key link in the pharmaceutical supply chain, but most do not meet the expectations of their pharma customers. <a href='http://www.trirx.com/'>TriRx</a> is building an integrated CDMO designed to fill the gap and be a reliable source of supply well into the future.
Manufacturing

How is TriRx Pharmaceutical Services evolving its business model to meet the future of healthcare?

<a href='http://www.trirx.com/'>TriRx Pharmaceutical Services</a>, one of That's Nice's Road to 2021 sponsors, discusses how the company is evolving its partnership models or geographic footprint to meet the future of healthcare?
Manufacturing

TriRx publishes 'Insights into the Evolution of a Changing Pharmaceutical Market'

The survey results explore supply chain challenges, demand volatility, dosage form trends, and more after a dramatic year
Subscribe now